Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akio Suzuki

Showing results (171-180 of 203) with videos related to

Pageof 21
Sort By:
The Oncologist|April 3, 2021
Low-Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin-Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II TrialChizuru Sakai, Mototsugu Shimokawa, Hirotoshi Iihara, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 14, 2020
Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapyChiemi Hirose, Hironori Fujii, Hirotoshi Iihara, et al.
Anticancer Research|February 28, 2023
Effect of Mirtazapine for the Prevention of Nausea and Vomiting in Patients With Thoracic Cancer Receiving Platinum-based ChemotherapyMotohiko Kinomura, Hirotoshi Iihara, Hironori Fujii, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2026
A community-based One Health approach to the pandemic dynamics of <i>Escherichia coli</i> ST131Aiko Maeda, Toyotaka Sato, Akira Fukuda, et al.
Anticancer Research|May 31, 2022
Control and Risk Factors of Nausea and Vomiting in Patients With Cervical Cancer Receiving RadiotherapyAkane Uno, Senri Yamamoto, Hirotoshi Iihara, et al.
Molecular and Clinical Oncology|March 7, 2022
Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancerHironori Fujii, Ayumu Araki, Hirotoshi Iihara, et al.
The Journal of Pain|January 11, 2024
Endothelial Glycocalyx in the Peripheral Capillaries is Injured Under Oxaliplatin-Induced NeuropathyTakahiro Kuroda, Akio Suzuki, Hideshi Okada, et al.
Scientific Reports|April 24, 2021
Serum syndecan-1 reflects organ dysfunction in critically ill patientsKeiko Suzuki, Hideshi Okada, Kazuyuki Sumi, et al.
Journal of Pharmaceutical Health Care and Sciences|March 3, 2022
Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapyHironori Fujii, Yukino Ueda, Chiemi Hirose, et al.
Journal of Diabetes Investigation|June 26, 2023
Effectiveness of countermeasure for polypharmacy by multidisciplinary team review in patients with diabetes mellitusShohei Nishida, Takehiro Kato, Yuichi Hayashi, et al.
Pageof 21

Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
The Oncologist|April 3, 2021
Low-Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin-Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II TrialChizuru Sakai, Mototsugu Shimokawa, Hirotoshi Iihara, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 14, 2020
Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapyChiemi Hirose, Hironori Fujii, Hirotoshi Iihara, et al.
Anticancer Research|February 28, 2023
Effect of Mirtazapine for the Prevention of Nausea and Vomiting in Patients With Thoracic Cancer Receiving Platinum-based ChemotherapyMotohiko Kinomura, Hirotoshi Iihara, Hironori Fujii, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2026
A community-based One Health approach to the pandemic dynamics of <i>Escherichia coli</i> ST131Aiko Maeda, Toyotaka Sato, Akira Fukuda, et al.
Anticancer Research|May 31, 2022
Control and Risk Factors of Nausea and Vomiting in Patients With Cervical Cancer Receiving RadiotherapyAkane Uno, Senri Yamamoto, Hirotoshi Iihara, et al.
Molecular and Clinical Oncology|March 7, 2022
Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancerHironori Fujii, Ayumu Araki, Hirotoshi Iihara, et al.
The Journal of Pain|January 11, 2024
Endothelial Glycocalyx in the Peripheral Capillaries is Injured Under Oxaliplatin-Induced NeuropathyTakahiro Kuroda, Akio Suzuki, Hideshi Okada, et al.
Scientific Reports|April 24, 2021
Serum syndecan-1 reflects organ dysfunction in critically ill patientsKeiko Suzuki, Hideshi Okada, Kazuyuki Sumi, et al.
Journal of Pharmaceutical Health Care and Sciences|March 3, 2022
Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapyHironori Fujii, Yukino Ueda, Chiemi Hirose, et al.
Journal of Diabetes Investigation|June 26, 2023
Effectiveness of countermeasure for polypharmacy by multidisciplinary team review in patients with diabetes mellitusShohei Nishida, Takehiro Kato, Yuichi Hayashi, et al.
Pageof 21